Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment

Lipocalin-2 (LCN2) promotes malignant development in many cancer types. LCN2 is upregulated in patients with pancreatic ductal adenocarcinoma (PDAC) and in obese individuals, but whether it contributes to PDAC development is unclear. In this study, we investigated the effects of Lcn2 depletion on di...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer Res
Main Authors: Gomez-Chou, Sobeyda B., Swidnicka-Siergiejko, Agnieszka Katarzyna, Badi, Niharika, Chavez-Tomar, Myrriah, Lesinski, Gregory B., Bekaii-Saab, Tanios, Farren, Matthew R., Mace, Thomas A., Schmidt, Carl, Liu, Yan, Deng, Defeng, Hwang, Rosa F., Zhou, Liran, Moore, Todd, Chatterjee, Deyali, Wang, Huamin, Leng, Xiaohong, Arlinghaus, Ralph B., Logsdon, Craig D., Cruz-Monserrate, Zobeida
格式: Artigo
語言:Inglês
出版: 2017
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5441230/
https://ncbi.nlm.nih.gov/pubmed/28249896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-1986
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍